Divozilimab
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Divozilimab, covering 2024-11-07 to 2025-08-22. Get the full timeline:
Most recent: Clinical Trial Update: Safety, Pharmacokinetics, Immunogenicity BCD-256-1 and Divozilimab in Subjects With Systemic Lupus Erythematosus [Phase 1]